Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price traded down 1.6% during trading on Monday . The stock traded as low as C$0.63 and last traded at C$0.63. 3,510 shares changed hands during trading, a decline of 83% from the average session volume of 21,132 shares. The stock had previously closed at C$0.64.
Crescita Therapeutics Stock Performance
The stock’s 50 day moving average is C$0.54 and its two-hundred day moving average is C$0.47. The firm has a market capitalization of C$12.21 million, a P/E ratio of -5.25 and a beta of 1.71. The company has a debt-to-equity ratio of 6.02, a current ratio of 3.37 and a quick ratio of 2.29.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Featured Stories
- Five stocks we like better than Crescita Therapeutics
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- What are earnings reports?
- 2 Option Strategies to Maximize Profits in a Bear Market
- Following Congress Stock Trades
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
